84 related articles for article (PubMed ID: 11861365)
1. Genomic amplification in retinoblastoma narrowed to 0.6 megabase on chromosome 6p containing a kinesin-like gene, RBKIN.
Chen D; Pajovic S; Duckett A; Brown VD; Squire JA; Gallie BL
Cancer Res; 2002 Feb; 62(4):967-71. PubMed ID: 11861365
[TBL] [Abstract][Full Text] [Related]
2. Expression analysis of 6p22 genomic gain in retinoblastoma.
Orlic M; Spencer CE; Wang L; Gallie BL
Genes Chromosomes Cancer; 2006 Jan; 45(1):72-82. PubMed ID: 16180235
[TBL] [Abstract][Full Text] [Related]
3. Profiling genomic copy number changes in retinoblastoma beyond loss of RB1.
Bowles E; Corson TW; Bayani J; Squire JA; Wong N; Lai PB; Gallie BL
Genes Chromosomes Cancer; 2007 Feb; 46(2):118-29. PubMed ID: 17099872
[TBL] [Abstract][Full Text] [Related]
4. Gains and overexpression identify DEK and E2F3 as targets of chromosome 6p gains in retinoblastoma.
Grasemann C; Gratias S; Stephan H; Schüler A; Schramm A; Klein-Hitpass L; Rieder H; Schneider S; Kappes F; Eggert A; Lohmann DR
Oncogene; 2005 Sep; 24(42):6441-9. PubMed ID: 16007192
[TBL] [Abstract][Full Text] [Related]
5. KIF14 is a candidate oncogene in the 1q minimal region of genomic gain in multiple cancers.
Corson TW; Huang A; Tsao MS; Gallie BL
Oncogene; 2005 Jul; 24(30):4741-53. PubMed ID: 15897902
[TBL] [Abstract][Full Text] [Related]
6. Delineation of the 6p22 amplification unit in urinary bladder carcinoma cell lines.
Bruch J; Schulz WA; Häussler J; Melzner I; Brüderlein S; Möller P; Kemmerling R; Vogel W; Hameister H
Cancer Res; 2000 Aug; 60(16):4526-30. PubMed ID: 10969802
[TBL] [Abstract][Full Text] [Related]
7. Defining a 0.5-mb region of genomic gain on chromosome 6p22 in bladder cancer by quantitative-multiplex polymerase chain reaction.
Evans AJ; Gallie BL; Jewett MA; Pond GR; Vandezande K; Underwood J; Fradet Y; Lim G; Marrano P; Zielenska M; Squire JA
Am J Pathol; 2004 Jan; 164(1):285-93. PubMed ID: 14695341
[TBL] [Abstract][Full Text] [Related]
8. Genomic gains on chromosome 1q in retinoblastoma: consequences on gene expression and association with clinical manifestation.
Gratias S; Schüler A; Hitpass LK; Stephan H; Rieder H; Schneider S; Horsthemke B; Lohmann DR
Int J Cancer; 2005 Sep; 116(4):555-63. PubMed ID: 15825178
[TBL] [Abstract][Full Text] [Related]
9. High resolution SNP array profiling identifies variability in retinoblastoma genome stability.
Mol BM; Massink MP; van der Hout AH; Dommering CJ; Zaman JM; Bosscha MI; Kors WA; Meijers-Heijboer HE; Kaspers GJ; Riele Ht; Moll AC; Cloos J; Dorsman JC
Genes Chromosomes Cancer; 2014 Jan; 53(1):1-14. PubMed ID: 24249257
[TBL] [Abstract][Full Text] [Related]
10. Novel 6p rearrangements and recurrent translocation breakpoints in retinoblastoma cell lines identified by spectral karyotyping and mBAND analyses.
Paderova J; Orlic-Milacic M; Yoshimoto M; da Cunha Santos G; Gallie B; Squire JA
Cancer Genet Cytogenet; 2007 Dec; 179(2):102-11. PubMed ID: 18036396
[TBL] [Abstract][Full Text] [Related]
11. Growth enhancement of normal human keratinocytes by the antisense oligonucleotide of retinoblastoma susceptibility gene.
Koike M; Ishino K; Ikuta T; Huh N; Kuroki T
Oncogene; 1995 Jan; 10(1):117-22. PubMed ID: 7824264
[TBL] [Abstract][Full Text] [Related]
12. Identification of CCND3 and BYSL as candidate targets for the 6p21 amplification in diffuse large B-cell lymphoma.
Kasugai Y; Tagawa H; Kameoka Y; Morishima Y; Nakamura S; Seto M
Clin Cancer Res; 2005 Dec; 11(23):8265-72. PubMed ID: 16322284
[TBL] [Abstract][Full Text] [Related]
13. Loss at chromosome arm 16q in retinoblastoma: confirmation of the association with diffuse vitreous seeding and refinement of the recurrently deleted region.
Gustmann S; Klein-Hitpass L; Stephan H; Weber S; Bornfeld N; Kaulisch M; Lohmann DR; Dünker N
Genes Chromosomes Cancer; 2011 May; 50(5):327-37. PubMed ID: 21305643
[TBL] [Abstract][Full Text] [Related]
14. A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma.
Friend SH; Bernards R; Rogelj S; Weinberg RA; Rapaport JM; Albert DM; Dryja TP
Nature; 1986 Oct 16-22; 323(6089):643-6. PubMed ID: 2877398
[TBL] [Abstract][Full Text] [Related]
15. Genetic profiling of chromosome 1 in breast cancer: mapping of regions of gains and losses and identification of candidate genes on 1q.
Orsetti B; Nugoli M; Cervera N; Lasorsa L; Chuchana P; Rougé C; Ursule L; Nguyen C; Bibeau F; Rodriguez C; Theillet C
Br J Cancer; 2006 Nov; 95(10):1439-47. PubMed ID: 17060936
[TBL] [Abstract][Full Text] [Related]
16. 6p abnormalities and TNF-alpha over-expression in retinoblastoma cell line.
Imbert I; Coignet LJ; Pellestor F
Cancer Genet Cytogenet; 2001 Jul; 128(2):141-7. PubMed ID: 11463453
[TBL] [Abstract][Full Text] [Related]
17. Deletions of a DNA sequence in retinoblastomas and mesenchymal tumors: organization of the sequence and its encoded protein.
Friend SH; Horowitz JM; Gerber MR; Wang XF; Bogenmann E; Li FP; Weinberg RA
Proc Natl Acad Sci U S A; 1987 Dec; 84(24):9059-63. PubMed ID: 3480530
[TBL] [Abstract][Full Text] [Related]
18. A novel human prostate-specific gene-1 (HPG-1): molecular cloning, sequencing, and its potential involvement in prostate carcinogenesis.
Herness EA; Naz RK
Cancer Res; 2003 Jan; 63(2):329-36. PubMed ID: 12543784
[TBL] [Abstract][Full Text] [Related]
19. Nonrandom chromosomal changes in retinoblastomas.
Pogosianz HE; Kuznetsova LE
Arch Geschwulstforsch; 1986; 56(2):135-43. PubMed ID: 3707294
[TBL] [Abstract][Full Text] [Related]
20. Identification of candidate tumor oncogenes by integrative molecular analysis of choroidal melanoma fine-needle aspiration biopsy specimens.
McCannel TA; Burgess BL; Rao NP; Nelson SF; Straatsma BR
Arch Ophthalmol; 2010 Sep; 128(9):1170-7. PubMed ID: 20837802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
